Strong Q2, Revenue YoY Growth, Profit Margin Expansion etc.Excluding the one-time net revenue for contact and vaccine tracing services and product sales related to the COVID-19 pandemic in Q2 2020, core revenue YoY growth was 13% compared with Q2 2020.
Gross profit margin in Q2 2021 increased YoY hitting 64% compared with 60% in Q2 2020.
VMD recorded strong profitability for another quarter in a row.
VMD recorded strong positive operating cash flow for another quarter in a row.
VMD recorded strong positive free cash flow for another quarter in a row.
VMD maintained a pristine balance sheet with a strong net cash position that went UP sequentially, and therefore VMD can continue implementing its growth strategy.
And this growth strategy is both organic growth and inorganic growth through the acquisition of other smaller names.